Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy

Introduction: During the COVID-19 pandemic, Lombardy (Northern Italy) Regional Health Council created hubs for cancer care, meant to be SARS-CoV-2-free pathways for cancer patients. The workflow of breast cancer (BC) radiotherapy (RT) in one of the hubs is presented here. Methods: Candidates to adjuvant RT during the pandemic peak of March-April 2020 were compared to those treated in the same period of 2019, and patient volume, deferral rate, and type of RT were analyzed. Statistics were calculated with χ2 or Fisher exact tests for categorical variables, and the Wilcoxon rank test for continuous variables. Results: In March-April 2020 the BC patient volume increased by 28% compared to the same period in 2019 (scheduled patients: 175 vs. 137) and amid travel restrictions it was kept high (treated patients: 136 vs. 133), mainly due to an influx from across Lombardy. RT schemes basically did not change, being already centered on hypofractionation. The increase of median time (67 vs. 74.5 days in 2019 and 2020, respectively) to the commencement of RT for low-risk patients was clinically negligible yet statistically significant (p = 0.03), and in line with the pertinent recommendations. No significant difference was found in the time interval between treatments and RT for high-risk patients. Concomitant chemoradiotherapy was avoided throughout the pandemic peak. Twenty-one women (13.6%) delayed either computed tomography simulation or RT commencement mainly because of COVID-19-related concerns and mobility restrictions. Conclusion: The workload for BC was high during the pandemic peak. Hubs allowed the continuation of oncologic treatments, while mitigating the strain on frontline COVID-19 hospitals.

[1]  Y. Lievens,et al.  Effect of COVID-19 pandemic on practice in European radiation oncology centers☆ , 2020, Radiotherapy and Oncology.

[2]  P. Poortmans,et al.  Cancer and COVID-19: what do we really know? , 2020, The Lancet.

[3]  M. Gasparri,et al.  Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) , 2020, The Breast.

[4]  R. Orecchia,et al.  Head and neck cancer radiotherapy amid COVID‐19 pandemic: Report from Milan, Italy , 2020, Head & neck.

[5]  M. Luppi,et al.  Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it! , 2020, European Journal of Cancer.

[6]  R. Corvò,et al.  COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)☆ , 2020, Radiotherapy and Oncology.

[7]  M. Gnant,et al.  ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer , 2020, ESMO Open.

[8]  L. F. Cazzaniga,et al.  COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy , 2020, Clinics in oncology.

[9]  G. Curigliano.  How to Guarantee the Best of Care to Patients with Cancer During the COVID‐19 Epidemic: The Italian Experience , 2020, The oncologist.

[10]  G. Pravettoni,et al.  Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic , 2020, The Breast.

[11]  M. Roumeliotis,et al.  Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations , 2020, Advances in Radiation Oncology.

[12]  L. Livi,et al.  Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists , 2020, ESMO Open.

[13]  B. Mueller,et al.  Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints—Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States , 2020, Advances in Radiation Oncology.

[14]  R. Jagsi,et al.  International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic , 2020, Clinical Oncology.

[15]  D. Hu,et al.  Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China☆ , 2020, Radiotherapy and Oncology.

[16]  M. Katz,et al.  COVID-19: Global radiation oncology’s targeted response for pandemic preparedness , 2020, Clinical and Translational Radiation Oncology.

[17]  G. Onder,et al.  Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.

[18]  S. Falivene,et al.  Present clinical practice of breast cancer radiotherapy in Italy: a nationwide survey by the Italian Society of Radiotherapy and Clinical Oncology (AIRO) Breast Group , 2020, La radiologia medica.

[19]  Jean L Wright,et al.  Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. , 2018, Practical radiation oncology.

[20]  J Bogaerts,et al.  ESMO-Magnitude of Clinical Benefit Scale version 1.1 , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Alphonse G. Taghian,et al.  Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. , 2017, Practical radiation oncology.

[22]  B. Gulluoglu,et al.  Breast Care , 2010, Breast Care.